Gene Query: EBNA1BP2

Dataset Description Geneva Score
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 85.03
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 85.03
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 50.11
FOXD3 is a novel tumor suppressor in lung cancer 47.42
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 44.04
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 40.46
Region-specific Innate Antiviral Responses of the Human Epididymis 37.63
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 36.51
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 32.96
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 32.79
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 32.07
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 31.53
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 30.28
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 30.03
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells 29.82
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 29.78
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 28.03
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 28.03
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 27.72
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 26.56
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 26.23
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts 26.15
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 25.56
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 25.56
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 25.46
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 25.46
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 22.91
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 22.88
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 22.8
SRSF1 role in cellular gene expression and splicing 22.77
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 22.6
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 22.57
RNA-seq of resting and activated CD4+ T cells +-JQ1 22.45
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 22.14
RNA-seq analysis of BAP1-depleted uveal melanoma cells 21.72
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 21.53
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 21.5
Hijacking of stress response machinery by oncogenes in acute leukaemia 21.49
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 21.49
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 21.42
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 21.42
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 21.21
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 21.21
Endothelial gene expression analysis 21.21
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 21.08
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 20.61
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 20.61
RNA-seq of shEZH2 cells 20.54
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 20.3
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 20.3
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 20.22
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 20.1
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 19.78
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 19.68
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 19.68
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 19.51
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 19.47
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 19.24
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 19.17
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 19.09
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 19.09
AUF-1 affected genes in human skin cells 18.86
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 18.83
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 18.62
The landscape of alternative splicing in aggressive prostate cancers 18.59
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 18.45
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 18.43
Lysine benzoylation is a novel histone mark 18.25
Lysine benzoylation is a novel histone mark [RNA-seq] 18.25
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 18.22
Genome wide miR-191 target profile determined by RIP and gene expression profiling 18.01
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 18.01
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 17.95
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 17.85
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 17.81
Transcriptome of activated human and mouse MAIT cells 17.71
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 17.69
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 17.67
Developmental stage specific chromosome architecture in human erythroid cells 17.67
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 17.4
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 17.38
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 17.33
hnRNP C is a key regulator of protein synthesis in mitosis 17.09
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 17.03
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 17.03
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 16.99
Expression level comparison under dividing and quiescent states in human primary fibroblasts 16.83
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 16.82
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 16.81
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 16.73
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 16.59
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 16.47
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 16.47
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 16.4
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 16.29
Genome wide expression change by RNF168 knocking down in NEC cells 16.23
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 16.06
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 15.92
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 15.92
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 15.91
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 15.82
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 15.82
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 15.73
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 15.73
Identification of Sin3B regulated genes during quiescence 15.54
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 15.35
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 15.34
TCF7L1 knockdown in pancreatic cancer 15.3
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 15.24
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 15.24
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 15.19
Chromatin landscape of human visceral and subcutaneous adipocytes 15.17
The comparison of high-throughput single-cell RNA-seq methods 15.16
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 15.06
Differetially expressed genes after hTR overexpression in U2OS cells 14.87
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 14.83
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 14.83
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 14.78
NRDE2 negatively regulates nuclear exosome functions 14.65
Gene expression profiling of leukemia cells following asparagine depletion 14.57
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 14.47
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 14.47
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 14.42
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 14.33
RNA sequencing of GlyH-101-treated MCF-7 cell line 14.31
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 14.28
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 14.28
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 14.23
Effect of FGF13 depletion on the H460 cell line 14.21
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 14.16
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 14.16
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 14.01
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 14.01
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 13.98
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 13.87
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 13.72
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 13.62
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 13.59
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 13.53
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 13.42
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) 13.4
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 13.37
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 13.24
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 13.19
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 13.1
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 13.06
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 13.02
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 13.02
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 12.99
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 12.94
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 12.92
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 12.89
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 12.89
A549 cells and MSR-A549 cells 12.85
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 12.85
RNA-seq analysis of uveal melanoma cells treated with FR900359 12.83
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 12.82
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 12.81
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 12.77
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 12.77
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 12.76
Transcription control by the ENL YEATS domain in acute leukemia 12.76
Global analysis of enhancer targets: Mosaic-seq 12.73
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 12.66
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 12.64
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 12.61
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 12.59
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 12.55
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 12.55
RNA-seq in transgenic cells 12.49
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 12.45
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 12.43
Overexpression and knockdown experiment for circCSNK1G3 12.41
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 12.24
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 12.23
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 12.18
Identification of global regulators of T-helper cell lineage specification 12.13
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 12.13
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 12.09
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 12.0
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 11.98
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 11.94
Comprehensive comparative analysis of 5’ end RNA sequencing methods 11.87
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 11.87
Hypoxic transcriptome of SQ20B human head and neck cancer cells 11.86
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 11.84
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 11.8
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 11.73
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 11.73
SETBP1-WT and SETBP1-G870S epigenetic landscapes 11.61
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 11.61
RNA-seq analysis of RALD iPSCs after in vitro differentiation 11.6
Trans-differentiation of human adult peripheral blood T cells into neurons 11.55
ETV7 and interferon response 11.4
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 11.4
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 11.39
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 11.23
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 11.2
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 11.14
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 11.13
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 11.12
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 11.12
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 11.11
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 11.06
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 11.04
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 11.04
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 11.01
Mitochondrial dsRNA triggers antiviral signalling in humans 11.01
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 10.98
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 10.93
Nucleoporin-mediated regulation of cell identity genes 10.92
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 10.88
RNA seq with AML (NB4) cells upon FTO inhibition 10.84
RNA-seq of young and quiescent MRC-5 human fibroblasts 10.75
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 10.71
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 10.68
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 10.66
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 10.55
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 10.54
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 10.51
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 10.49
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 10.49
Differential expression of genes in AD169-infected MRC5. 10.45
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 10.42
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 10.41
scRNASeq analysis of cycling cardiomyocytes 10.25
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 10.2
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 10.2
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 10.14
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 10.14
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 10.1
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 10.06
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 10.01
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 10.01
Role of microRNAs in the interaction between Salmonella and the host cell 9.99
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 9.99
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 9.95
Regulating Interleukin-2 activity with engineered receptor signaling clamps 9.92
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 9.86
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 9.86
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 9.84
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 9.84
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 9.83
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 9.78
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 9.76
Ribosomal footprinting of CN34-Parental and CN34-LM1a 9.75
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 9.73
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 9.73
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 9.67
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 9.66
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 9.66
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 9.59
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 9.51
RNA sequencing of primary human platelets and in vitro cell lines 9.48
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 9.43
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 9.37
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 9.37
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 9.34
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 9.23
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 9.22
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 9.21
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 9.17
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 9.09
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 9.03
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 9.01
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 9.01
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 8.99
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 8.99
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 8.99
MeRIP-seq for heat shock in B-cell lymphoma cells 8.95
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 8.93
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 8.91
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 8.91
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 8.89
Solid phase chemistry to covalently and reversibly capture thiolated RNA 8.89
Knockdown of ADNP in HCT116 colon cancer cells 8.83
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 8.73
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 8.71
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 8.71
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 8.69
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 8.67
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 8.64
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 8.61
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 8.61
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 8.61
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 8.53
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 8.5
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 8.47
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 8.47
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 8.47
KLF6-dependent transcription in renal cancer cells 8.41
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 8.4
Transcriptome-wide identification of CELF2 functional targets in T cells 8.23
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 8.2
Mapping interactions for the TNIP2 hub protein 8.16
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 8.13
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 8.13
Total RNA-seq in ALL-SIL upon JQ1 inhibition 8.1
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 8.07
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 8.07
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 8.07
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 8.01
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 8.01
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 8.01
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 8.01
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 7.99
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 7.94
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 7.92
Fbxo32 mediated gene expression program underlies EMT and metastasis 7.92
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 7.91
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 7.9
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 7.8
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 7.78
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 7.77
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 7.77
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 7.76
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 7.76
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 7.75
A map of gene expression in neutrophil-like cell lines 7.69
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 7.65
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 7.65
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 7.52
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 7.5
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 7.5
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 7.47
Human Treg IL-12 stimulation 7.26
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 7.24
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 7.23
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 7.21
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 7.19
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 7.19
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 7.18
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 6.98
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 6.98
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 6.94
O-glcnAc reprograms cellular energetics 6.9
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 6.9
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 6.74
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 6.73
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 6.72
Selective expression of long non-coding RNAs in a breast cancer cell progression model 6.62
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 6.58
Human cells contain natural double-stranded RNAs with potential regulatory capacity 6.56
An integrative analysis of non-coding regulatory DNA variations associated with autism 6.51
FOXP2's impact on the primate transcriptome 6.44
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 6.42
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 6.34
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 6.29
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 6.26
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 6.25
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 6.21
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 6.18
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 6.16
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 6.14
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 6.14
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 6.1
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 6.09
Transcriptome analysis upon C6orf203 silencing 6.02
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 6.02
Efficient derivation of microglia-like cells from human pluripotent stem cells 5.99
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 5.98
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 5.94
Positively selected enhancer elements endow tumor cells with metastatic competence 5.85
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 5.84
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 5.71
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 5.71
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 5.69
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 5.54
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 5.53
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 5.53
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 5.49
p63 controls the enhancer landscape during keratinocyte differentiation 5.48
Alagille_Nodder 5.45
RNA Seq of Alagille liver biopsies 5.45
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 5.42
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 5.41
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 5.39
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 5.37
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 5.35
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 5.31
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 5.26
MYCi975 regulates MYC target genes 5.15
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 5.13
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 5.06
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 5.05
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.99
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 4.98
Gene expression profile of multiple myeloma cell lines treated with CB-5083 4.97
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 4.96
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 4.95
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 4.95
The DPYSL2 gene connects mTOR and schizophrenia 4.95
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 4.85
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 4.82
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 4.75
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 4.7
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 4.62
Primary Human B-cell Temporal Response to CD40L Stimulation 4.58
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 4.49
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 4.42
Ribosome profiling upon inhibition of eIF4A 4.41
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 4.35
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 4.33
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 4.22
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 4.08
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 4.08
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 4.06
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 4.04
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells 4.03
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 4.03
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 4.0
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 3.97
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 3.97
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 3.97
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 3.92
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 3.86
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 3.86
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 3.83
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 3.77
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 3.68
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 3.65
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 3.61
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 3.58
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 3.54
RNA-seq analysis upon ARID1B overexpression 3.54
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 3.52
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 3.43
Polarized B -cell functions 3.19
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.19
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 3.16
SF3B1 Degron knockdown RNA-seq 3.12
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 3.1
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 3.1
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 3.02
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 2.92
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 2.88
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 2.87
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 2.84
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 2.75
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 2.74
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 2.72
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 2.72
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.7
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 2.61
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 2.61
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 2.57
An siRNA screen identifies CHD4 as a target for epigenetic therapy 2.48
RNA-seq data 2.45
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 2.4
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 2.4
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 2.37
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.19
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 2.13
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 2.03
Gene expression profile of CRC-derived HILEC 2.03
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.98
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 1.97
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 1.95
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 1.92
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.87
Effects of transcription on genome - nuclear lamina interactions 1.83
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.83
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 1.82
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 1.77
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 1.63
U2AF1 mutations alter splice site recognition in hematological malignancies 1.5
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.49
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 1.46
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.41
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.29
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.29
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 1.28
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 1.23
Exogenous rescue of KLHL9 in SF210 cell line 1.18
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 1.16
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 1.16
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 1.13
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 1.02
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 1.0
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 1.0
Global transcriptome analysis of WT versus HEB-/- hESCs 0.93
Impact on erythroid progenitor type on erythroid differntiation 0.91
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.73
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.67
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.63
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.59
Gene expression changes due to PARP knockdown in human cells 0.55
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 0.42
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.39
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.37
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.37
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.21
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.21
RNA seq analysis of human Fetal and adult derived Enterospheres 0.21
Transcriptome profiling of 5 human adenocarcinoma cell lines 0.19
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.15
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.13
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.12
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.08
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation